Triplet repeat expansions in the Fragile X mental retardation 1 (FMR1) gene cause either intellectual disability and autism, or adult-onset neurodegeneration, with poorly understood variability in presentation. Previous studies have identified several long noncoding RNAs (lncRNAs) at the FMR1 locus, including FMR4. Similarly to FMR1, FMR4 is silenced by large-repeat expansions that result in enrichment of DNA and histone methylation within the shared promoter and repeat sequence, suggesting a possible role for this noncoding RNA in the pathophysiology of Fragile X. We therefore assessed the functional role of FMR4 to gain further insight into the molecular processes in Fragile X-associated disorders. Previous work showed that FMR4 does not exhibit cis-regulation of FMR1. Here, we found that FMR4 is a chromatin-associated transcript and, using genome-wide chromatin immunoprecipitation experiments, showed that FMR4 alters the chromatin state and the expression of several hundred genes in trans. Among the genes regulated by FMR4, we found enrichment for those involved in neural development and cellular proliferation. S-phase marker assays further demonstrated that FMR4 may promote cellular proliferation, rather than differentiation, of human neural precursor cells (hNPCs). By establishing this novel function for FMR4 in hNPCs, we lend support to existing evidence of the epigenetic involvement of lncRNA in nervous system development, and increase our understanding of the complex pathogenesis underlying neurological disorders associated with FMR1 repeat expansions.
Introduction
Fragile X syndrome (FXS) is a common cause of inherited intellectual disability and the leading known genetic cause of autism (Miles, 2011) . FXS is an X-linked disorder arising from a triplet repeat expansion in the FMR1 gene. FMR1 repeat alleles are generally grouped into three categories: those containing a normal number of repeats (6-54), premutations (55-200 repeats) and full mutations (greater than 200 repeats). While only the full mutation leads to FXS, individuals with the premutation are at risk for developing Fragile X-related primary ovarian insufficiency (FXPOI) and/or an adult-onset, neurodegenerative condition known as Fragile X-associated tremor/ataxia syndrome (FXTAS) (Oostra and Willemsen, 2003) . The production of expanded mRNAs from premutated alleles underlies FXPOI and FXTAS pathology via toxic RNA gain of function (Kenneson et al., 2001; Tassone et al., 2000) . By contrast, full mutations increase DNA and repressive histone methylation levels at the FMR1 locus (Coffee et al., 2002; Coffee et al., 1999; Hornstra et al., 1993; Kumari and Usdin, 2010; Sutcliffe et al., 1992) , thereby inducing the loss of FMR1 mRNA and protein (Fragile X mental retardation protein, FMRP). The FMR1 locus encodes expression of four other transcripts in addition to FMR1 mRNA Ladd et al., 2007; Pastori et al., 2014) . Importantly, expression of three of these transcripts is dysregulated in individuals with Fragile X repeat expansions and may modulate variability in penetrance and severity of the FXS/FXTAS phenotypes.
Long (N 200 nucleotides (nt) ) and short non-coding RNAs (ncRNAs) make up roughly 80% of the human transcriptome (Banfai et al., 2012; Cheng et al., 2005; Djebali et al., 2012) . Short non-coding RNAs, which range from 15 to 200 nt and are either double or single-stranded (e.g. piRNAs and microRNAs, respectively) have been shown to regulate gene expression through posttranscriptional mechanisms such as degradation of target messenger RNA (mRNA) or inhibition of translation (Fabian and Sonenberg, 2012; Rother and Meister, 2011) . Long non-coding RNAs (lncRNAs), which can range from 200 nt up to several kilobases in length, can modulate transcription of protein-coding genes at either their own locus (cis-regulation) or distant loci (trans-regulation) by altering the chromatin state. Several mechanisms have been proposed for the latter; for example lncRNAs can provide a scaffold for chromatin-modifying complexes or guide ribonucleoprotein complexes to target loci (Pastori et al., 2010; Wang and Chang, 2011; Yamanaka et al., 2015) . In addition, some lncRNAs modulate gene expression post-transcriptionally through inhibition of translation, modulation of splicing, and/or editing of the protein-coding sequence of mRNAs. Through these various effects on gene regulation, lncRNAs have important biological roles such as in DNA damage response and cellular senescence (Hung et al., 2011; Kotake et al., 2011; Pastori et al., 2015; Tsai et al., 2010; Wang and Chang, 2011; Yap et al., 2010) .
While the full spectrum of lncRNA functionality is unknown, many of their neurobiological and neuropathological roles have been described (Pastori and Wahlestedt, 2012) . Transcriptomic studies of the brain have revealed that several lncRNAs regulate brain development, synaptic signaling mechanisms, differentiation toward the neural cell lineage and formation of mature neuronal connections (Mercer et al., 2010; Qureshi et al., 2010) . Paternal deletion of small nucleolar ncRNAs in a maternally imprinted region causes the developmental and metabolic disorder Prader-Willi Syndrome (de Smith et al., 2009; Sahoo et al., 2008) , but this region also encodes a lncRNA, whose loss may contribute to dysregulation of circadian rhythm and energy expenditure in these patients (Powell et al., 2013) . Several reports have suggested that aberrant expression of lncRNA originating from known autism spectrum disorder (ASD) susceptibility loci (Velmeshev et al., 2013; Ziats and Rennert, 2013) may be linked to other syndromic and non-syndromic ASDs. In addition, lncRNAs may be involved in the pathogenesis of idiopathic and genetically acquired neurodegenerative diseases such as Alzheimer's disease and spinocerebellar ataxia type 7, which is also a repeat expansion disorder (Sopher et al., 2011) . These findings suggest that lncRNAs play a role in brain development and function, as well as in diseases of the CNS.
We previously identified FMR4, an antisense lncRNA derived from the FMR1 gene locus with anti-apoptotic functions in non-neuronal cells . FMR4 exerted these functions independently of FMR1 gene regulation and was not translated in vitro suggesting that FMR4 might be a trans-acting lncRNA. Here, we report an interaction between FMR4 and chromatin that may lead to FMR4-dependent effects on global histone methylation and mRNA expression. Also, we confirm FMR4 functionality by demonstrating that overexpression of this lncRNA promotes proliferation of human neural precursor cells (hNPCs).
Materials and methods
2.1. HEK293T cell culture, transfection and RNA extraction HEK293T cells were cultured in DMEM with 10% fetal bovine serum. Cells were transfected with pcDNA3.1-FMR4 or empty pcDNA3.1 control vector for overexpression, or FMR4(C) cDNA libraries were created using the High Capacity cDNA Reverse Transcription Kit (Life Technologies) with 500 ng of total RNA starting material. FMR4 cDNA was synthesized separately using strand specific priming ("FMR4 RT": ATTGCTGGCAGTCGTTTCTT), while all other genes were measured from random hexamer-primed cDNA libraries. FMR4 RNA expression was quantified using SYBR Green qPCR with the following primers, validated by melting curve: "FMR4 FW" -ACCAAA CCAAACCAAACCAA and "FMR4 REV" -GTGGGAAATCAAATGCATCC. All other transcripts were measured using commercially available TaqMan probes (Life Technologies). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an endogenous control where applicable, and data were analyzed by the Delta Delta Ct method.
Subcellular fractionation
HEK293T cells were trypsinized and centrifuged at 500 × g. The pellet was washed with PBS and fractionated using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Waltham, MA, USA) according to the manufacturer's instructions. Briefly, cells were first lysed and centrifuged to separate pelleted nuclei from cytoplasm. Then, nuclei were lysed and a final centrifugation step separated chromatin from other nuclear components. RNA was extracted from each fraction using Trizol or Trizol LS (for supernatant samples), and cDNA was prepared using random primers for control transcripts (Malat1 and GAPDH) and FMR1, and gene-specific priming for FMR4 as noted above. 2 μL total RNA was used as starting material in each cDNA reaction (rather than equal mass of RNA), in order to compare the absolute quantities of each transcript found in the three compartments. Relative quantification (RQ) for each transcript in each compartment was determined from Cq values by qPCR. RQ values for each transcript in each fraction were normalized to the total detected amount of individual transcripts.
Chromatin immunoprecipitation-on chip (ChIP-chip)
24 h after transfection, HEK293T cells were collected, cross-linked with formaldehyde and processed using the EZ-Magna ChIP™ kit (Millipore, Germany) according to the manufacturer's instructions. In brief, cells were lysed and sonicated to achieve 100-500 bp DNA fragments. After sonication the chromatin was immunoprecipitated with antibodies for trimethylated histone H3 at lysine 27 (H3K27Me3, Millipore, cat#07-449), trimethylated histone H3 at lysine 4 (H3K4Me3, Millipore, cat#07-473) and with the rabbit IgG antibody (Abcam, UK, cat# ab46540) as a negative control. DNA-protein crosslinks were reversed and DNA was purified from both an aliquot representing the total cell lysate (Input) and the immunoprecipitated samples. ChIP experiments were repeated four times and samples submitted to Roche (Switzerland) for the NimbleGen Chromatin Immunoprecipitation-on-chip (ChIP-chip) Service for hybridization against oligonucleotide probes in NimbleGen 3x720K tiling arrays representing 19,338 'unique' promoter regions annotated to the hg18 human RefSeq database. Each transcription start site was tiled 3200 bps upstream and 800 bps downstream. The median probe spacing was 104 bps. The scaled log2 ratio for each feature on the array was computed and scaled to center the ratio data around zero by subtracting the bi-weight mean for the log2-ratio values. Peak data files were then generated from the scaled log2-ratio data. The NimbleScan software detected peaks by searching for 4 or more probes whose signals were above the specified cutoff values, ranging from 90% to 15%, using a 500 bp sliding window. If there were fewer than 4 probes per window, NimbleScan searched for 3, then 2 probes in the window (with 2 being the minimum). The cutoff values were a percentage of a hypothetical maximum, which was the mean + 6[standard deviation]. The ratio data was then randomized 20 times to evaluate the probability of false positives. Based on this randomization and probability, each peak was assigned a false discovery rate (FDR) score. Peaks with an FDR ≤ 0.2 were prioritized for comparisons between FMR4 overexpression cells and control cells. Furthermore, only gene promoters showing such peaks in at least 2 of the 4 samples within either the control or overexpression condition were considered, yielding 8049 gene promoters in the H3K4Me3 samples and 7846 gene promoters in the H3K27Me3 samples for analysis. For each antibody, a Student's t-test was performed to find significant differences (p b 0.05) between control and overexpression experiments. Lists of genes with significant differences for H3K4Me3 or H3K27Me3 were entered into the GeneGo Metacore program for determination of overrepresented biological pathways and processes using their proprietary software.
Human neural precursor cell (hNPC) culture, differentiation and viral transduction
hNPCs were isolated from human fetal brains collected from 110-day aborted fetuses received from the Birth Defects Research Lab at the University of Washington in Seattle. Review by the Human Subject Research Office at the University of Miami classified this work as "NonHuman Subject Research"; it was therefore not subject to Institutional Review Board approval. Briefly, dissected brain tissues were enzymatically dissociated into single cells using the Neural Tissue Dissociation Kit (Miltenyi Biotec, Germany, cat #130-093-231) and seeded at a density of 5 × 10 6 cells in 75-mm tissue culture flasks in proliferation media supplemented with B27, human Epidermal Growth Factor (hEGF) at 20 ng/mL and human Fibroblast Growth Factor (hFGF) at 10 ng/mL. After 7-10 days of culture, neural stem cells form neurosphere colonies, whereas other cell types remain in suspension as single cells or attach to the bottom of the flask. The isolated hNPCs can be cultured as neurospheres in suspension for several months using proliferation media. hNPCs were also differentiated in vitro into a mixed population of neurons and astrocytes. To induce differentiation, neurospheres were disaggregated into single cells using Accutase (Innovative Cell Technologies, San Diego, CA, USA) and cultured in tissue-cultured treated 6-well or 24-well plates in Advanced DMEM/F12 media without hFGF or hEGF, containing Bottenstein's N2 (Invitrogen) and 2.5% fetal bovine serum. Differentiating hNPCs were transduced with a lentiviral vector expressing FMR4 (pLentiCMV/TO-mCherry-FMR4) or the control vector (pLentiCMV/TO-mCherry) 24 h after Accutase dissociation, and media was changed at 24 h post-transduction.
Immunocytochemistry
hNPCs grown in differentiation media for 1, 5, 8 and 15 days were processed for immunofluorescent detection of neuronal and glial lineage markers. After fixation with 4% paraformaldehyde and 30% sucrose, cells were blocked with 10% normal goat serum, permeabilized with 0.2% Triton-X and incubated overnight at 4°C with anti-GFAP (Millipore, cat#MAB360) and one of the following: anti-DCX (Millipore, cat#AB2253), anti-Nestin (Millipore, cat#MAB5326), anti-βIII-Tubulin (Covance, Princeton, NJ, USA, cat#MRB-435P) or anti-MAP2 (Abcam cat#ab5392) antibodies. Cells were counterstained with Hoescht 33342 and AlexaFluor 488 and AlexaFluor 594-conjugated secondary antibodies were used to detect primary antibodies (Life Technologies).
2.7. 5-Ethynyl-2′-deoxyuridine (EdU) assay hNPCs were dissociated with Accutase and 5 × 10 4 cells/well were then plated in differentiation media in 24-well tissue culture dishes as described above. At 1, 5, 8 and 15 DIV, hNPCs were incubated with 10 nM EdU for 6 h, fixed with 4% paraformaldehyde plus 30% sucrose for 15 min, washed with 1% bovine serum albumin in phosphate buffered saline and fluorescently labeled with the Click-iT® EdU Alexa Fluor® 488 Imaging Kit (Life Technologies, cat# C10337) according to the manufacturer's instructions. Cells were counterstained with the nuclear dye Hoechst 33342 and scanned using the Arrayscan VTI instrument (Thermo Scientific). Nuclei were traced using the Target Activation Bioapplication, and the proportion of dividing cells was quantified based on colabeling with Hoechst and EdU.
Statistical analyses
Prior to hypothesis testing, all data sets were confirmed to follow a normal distribution using the Shapiro-Wilk test (data not shown); they were subsequently determined to meet assumptions for parametric testing. For subcellular fractionation experiments, differences in normalized RQ values representing FMR4 localization to each of the three compartments (Cytoplasmic, Nuclear and Chromatin) were detected using a One-way ANOVA with the Tukey HSD post-hoc test. Fold changes in FMR4 expression induced by overexpression with pcDNA3.1 or the lentiviral vector, or knockdown with siRNA were assessed using a Student's t-test. Validation of expression changes in putative FMR4-sensitive genes identified by ChIP-on-chip were analyzed by Student's t-test. Differences in expression of FMR4 in hNPCs between 1, 5, 8 and 15 DIV were determined by One-way ANOVA with the Tukey HSD post-hoc test. The proportion of EdU-positive hNPCs in the control and FMR4-overexpression conditions were compared using a Student's t-test. For all analyses, statistical significance is indicated in the figures as follows: * = p b 0.05, ** = p b 0.01, and *** = p b 0.001.
Results
Previously, we identified a 2.4 kb, non-coding antisense RNA starting in the 5′ UTR of the FMR1 gene, termed FMR4 . We found that FMR4 does not affect FMR1 expression, and that it is an anti-apoptotic and cell-proliferative gene in HEK293T and HeLa cells. This observation led us to hypothesize that FMR4 promotes cellular proliferation through trans-regulation of gene expression in the nucleus. We were interested in the potential implications of FMR4 function on neurodevelopment, and conducted our work using two human cell culture systems. After establishing that both cell types express FMR4 at baseline ( Supplementary Fig. 1 ), we performed initial subcellular fractionation and genome-wide studies in HEK293T cells. For subsequent analyses of FMR4 function we used human fetal-derived neurospheres (hNS). Neurospheres represent a pure population of neural precursor cells that can be expanded or induced to form differentiated neural and glial cells (see methods); we have taken advantage of this property in the work presented here.
Subcellular distribution of FMR4 transcript
Coding RNA transcripts are most abundant in the cytoplasm, where their translation occurs, whereas many lncRNAs localize primarily to the nucleus (Duszczyk et al., 2011; Gutschner et al., 2013) . For example, the lncRNA NEAT2/Malat1 has been shown to form nuclear foci, and has been linked to the biology of multiple human cancers (Bertrand et al., 1998; Gutschner et al., 2013) . Since the subcellular distribution of a particular RNA might provide insight into its functional role, we measured FMR4 levels in the soluble nuclear, cytoplasmic and in the chromatin fractions from HEK293T cells, relative to transcripts with known localization. 79.8% of GAPDH and 74.0% of FMR1 RNA (known cytoplasmic transcripts) were found to be in the cytoplasm (Fig. 1A) , in both cases significantly greater than either the soluble nuclear or the chromatin fractions. However, Malat1 was 62.9% nuclear, compared with 35.6% in the chromatin and only 1.5% cytoplasmic (Fig. 1B) . By comparison, the chromatin fraction contained 83.9% of total FMR4, a significant difference from both the nucleus and cytoplasm (Fig. 1B) .
Genome-wide analyses of FMR4-induced changes in promoter histone methylation
The finding that FMR4 is chromatin-associated supported our hypothesis that although FMR4 is not cis-active, it may have generegulatory activity in trans. To further establish whether this regulation occurs through an epigenetic mechanism, we conducted a genomewide assessment of chromatin status by measuring histone promoter methylation in response to overexpression of FMR4. We focused on changes in trimethylation of lysine 4 on histone H3 (H3K4Me3), a marker of gene activation, and trimethylation of lysine 27 on histone H3 (H3K27Me3), a marker of gene promoter repression. 24 h after transfection of HEK293T cells with either the empty control (pcDNA3.1) or the FMR4 overexpression vector (pcDNA3.1-FMR4) (Fig. 1C) , we performed chromatin immunoprecipitation (ChIP) of H3K4Me3 and H3K27Me3 followed by hybridization to human gene promoter arrays. Analysis of these ChIP-on-chip data for changes in either H3K4Me3 or H3K27Me3 peak intensities between FMR4 overexpression and control samples revealed 430 gene promoter regions with significantly altered histone methylation status (Fig. 1D) . Promoters with altered methylation in response to FMR4 overexpression were grouped by the direction in which the gene expression would be predicted to change. Of these 430 gene promoters, 92 gene promoters had increased H3K4Me3 levels, consistent with gene activation, whereas 86 had decreased H3K27Me3, predicting derepression of the promoter. Hence, a total of 178 gene promoters were regulated concordantly with respect to FMR4. On the other hand, 137 gene promoters showed decreased H3K4Me3 levels and 115 gene promoters had significantly increased H3K27Me3, thus predicting discordant regulation to FMR4 and decreased expression of 252 genes. 
Pathway analysis and FMR4 target validation
Pathway analysis of the FMR4-sensitive genes identified by promoter methylation (Tables 1 & 2) using GeneGo Metacore identified cell cycle regulation and apoptosis as highly ranked biological processes affected by FMR4, consistent with our earlier findings .
Additionally, FMR4-sensitive genes are enriched in neurobiological processes (e.g., synaptic contact, long term potentiation). While histone methylation marks are a widely accepted representation of promoter activity, the histone code is complex and it can be difficult to extrapolate the outcome on the mRNA expression level based on a single mark (Kouzarides, 2007) . We therefore validated a subset of putative FMR4 target genes including those from highly significant and functionally relevant pathways identified by ChIP-on-chip analysis using HEK293 cells with overexpressed FMR4 and cells with FMR4 knocked down (siRNA against FMR4 or a scrambled control siRNA for 72 h, as shown in Fig. 1C ). We confirmed that the mRNA expression of several of these genes, including brain-derived neurotrophic factor (BDNF), serotonin receptor 1D (HTR1D), cyclin-dependent kinase inhibitor 2A (p16), roundabout axon guidance receptor homolog 2 (ROBO2), semaphorin 3E (SEMA3E), followed the pattern anticipated based on changes detected in the chromatin modification state of their promoters (Fig. 1E,F) .
Human neural precursor cell differentiation
To further examine FMR4 functionality in neurodevelopment, we developed and characterized an in vitro model system using human fetal-derived neurospheres. By 15 days of in vitro (DIV) hNS differentiation, a portion of cells display increasing neurite outgrowth and stain positively for early neuronal markers (MAP2, doublecortin (DCX), β-Tubulin III) but are negative for the astrocytic marker glial fibrillary acidic protein (GFAP) ( Fig. 2A-C) and the neural stem cell marker nestin (data not shown). The remaining majority of cells represents a mixture of differentiated astrocytes positive for GFAP ( Fig. 2A-C) and undifferentiated neural stem cells expressing both GFAP and Nestin (data not shown) but not neuronal markers, as judged by immunocytochemistry (ICC) ( Fig. 2A-C) . These differentiated cultures are a heterogeneous mixture of neuronal and glial cell types that mirror the composition of brain tissues.
In order to examine the normal time-course of NPC cell-cycle cessation during induction of differentiation, we measured the uptake of 5-ethynyl-2′-deoxyuridine (EdU) as a marker of cell division in dissociated hNPCs plated in differentiation media (see Section 2). EdU is a nucleoside that is incorporated into DNA during S-phase and can be fluorescently detected (Fig. 3A) . We found that a higher proportion (16%) of cells were proliferating at 5 DIV, compared to the observed 2-4% of cells at (Fig. 3B) . We also determined that on average, throughout this 15-day period, cells were dividing once per 7-10 days (data not shown).
FMR4 and proliferation of hNPCs
Given the previous finding that FMR4 positively regulates proliferation of HEK293T and HeLa cells , we hypothesized that FMR4 would have a similar role in proliferation of hNPCs. To test this, we overexpressed FMR4 in dissociated hNS using a lentiviral vector approach (Fig. 4A) . Transfection efficiency was monitored using a reporter construct containing the mCherry fluorescent protein, which demonstrated robust expression by 5 days in vitro (DIV) (Fig. 4B) . After 5 DIV in differentiation media we observed that with FMR4 overexpression, the proportion of cells proliferating was 250% that of controls, as measured by EdU incorporation (Fig. 4B, C) . Collectively these studies suggest that FMR4 promotes proliferation of hNPCs.
Discussion
While decades of research have focused on the pathological consequences of FMR1 mRNA loss of function, relatively little attention has been given to the ncRNAs produced from this locus. Many ncRNAs have demonstrated regulatory influences on normal biological pathways, as well as roles in disease states as described above. Here we demonstrate that at least one lncRNA deriving from the complex FMR1 locus, FMR4, may be involved in neurodevelopment, suggesting that perturbation in its expression could affect outcomes in Fragile X syndrome and/or Fragile X tremor/ataxia syndrome. We have determined that overexpression and/or knockdown of FMR4 results in genome-wide changes in histone methylation that are reflected at the mRNA level. Several of the affected genes have known developmental or neurophysiological roles; along with the finding that FMR4 increases proliferation, our results support a role for FMR4 in regulating the development of hNPCs.
Our findings suggest that FMR4 may belong to the category of transacting lncRNAs, such as HOTAIR, MALAT-1 and GAS5, which act at distant genomic loci (Kino et al., 2010; Miyagawa et al., 2012; Rinn et al., 2007) rather than the protein-coding gene at their locus of origin (cis-acting). By forming scaffolds for recruiting histone modifying complexes or other proteins, affecting mRNA stability, splicing or editing, or through other mechanisms yet to be described, trans-acting transcripts are involved in dynamic regulation of gene expression. To better understand the molecular mechanism by which this transcript affects gene expression, and whether it plays a role in RNA metabolism, future studies should probe FMR4 interactions with protein. Furthermore, many studies have revealed FMRP's numerous interactions with downstream targets as a translational repressor and an RNA-binding protein, linking the loss of these functions to Fragile X. The work presented here lends further complexity to this picture, suggesting that additional, lncRNA-based mechanisms can help explain aspects of the observed phenotypes.
In this study, we confirmed that in HEK293T cells, manipulation of FMR4 causes differential expression of genes important to neuronal development and function, such as BDNF, Sema3E, ROBO2 and HTR1D. It should be noted that there could be additional unidentified targets. While we focused on two of the best-characterized, canonical histone modifications, regulation of mRNA expression by FMR4 may not be fully captured by H3K4Me3 and H3K27Me3. Multiple modifications can exist simultaneously, at a variety of locations throughout a gene and often with complex combinatorial effects that make it difficult to predict their regulation of gene expression at a particular locus. Nevertheless, by validating changes in chromatin state at the level of mRNA, we gain confidence in the influence of H3K4Me3 and H3K27Me3 on expression of these genes. Furthermore, any of these changes could result from direct epigenetic or other regulatory actions of FMR4 or from indirect, downstream effects. A further caveat to these results is the possibility that they are in response to the significantly elevated levels of FMR4 achieved in our overexpression experiments, which may not be seen in normal biological variation. Nevertheless, perhaps these effects are indicative of FMR4 steering these cells toward a more specialized fate, as has been described for other lncRNAs in embryonic stem cells (Yin et al., 2015) , human T-lymphocytes (Spurlock et al., 2015) and in the nervous system (Mercer et al., 2010) . The finding that FMR4 may promote proliferation of hNPCs further supports a role for FMR4 in neural development. To better understand how this lncRNA regulates proliferation, it would be necessary to more closely examine the timing and identify elements, such as transcription factors or other developmental regulators, which directly enhance or repress FMR4 transcription. Developmentally prescribed variations in expression of this chromatin-associated lncRNA would affect FMR4's ability to form three-dimensional chromatin structures, connecting distant genomic elements including promoters and enhancers (Ma et al., 2014) . Here, as with the general body of evidence on lncRNA, much work remains to be done to fully understand which properties of FMR4 and similar transcripts are the key determinants of function in relation to neural development.
Conclusions
Our studies suggest that lncRNAs, including FMR4, have important roles to play in normal human neurobiology and in the pathogenesis of the Fragile X repeat expansion-associated disorders. We confirm that FMR4 is an active regulator of gene expression, and suggest that this function may be related to the proliferative capacity of hNPCs during development. This chromatin-associated transcript likely acts by complexing with other RNA, DNA and proteins. Studying this primate-specific lncRNA broadens the scope of investigation into the specialized, higher-order processes underlying the pathogenesis of Fragile X syndrome and FXTAS, and this should yield useful information regarding future drug targets for these conditions. Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.mcn.2016.03.008.
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